Is GMTX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Gemini Therapeutics, Inc. 10 years ago, but if you had invested on Monday 8th of February 2021 when the price was $12.10, you would have made a loss of $-10.75 per share or -88.84%
No, the average daily trading liquidity for Gemini Therapeutics, Inc. is $217 588 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Gemini Therapeutics, Inc. has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Gemini Therapeutics, Inc. to be low [0 out of 1]